Literature DB >> 31341802

Changes in ocular surface status and dry eye symptoms following femtosecond laser-assisted cataract surgery.

Rui-Hong Ju1, Yun Chen1, Hai-Song Chen1, Wei-Jian Zhou1, Wei Yang1, Zhen-De Lin1, Zhe-Ming Wu1.   

Abstract

AIM: To observe the changes in ocular surface and the dry eye symptoms following femtosecond laser-assisted cataract surgery (FLACS).
METHODS: Patients with no eye signs or symptoms in Guangzhou Aier Eye Hospital between October 2017 and September 2018, who underwent FLACS and intraocular lens (IOL) implantation for age-related cataract were enrolled. Tear film stability assessed with OCULUS Keratograph 5M, Schirmer's I test (SIT), and corneal fluorescein staining (CFS) were evaluated before and after surgery at 1d, 1wk, 1, and 3mo in order. Ocular Surface Disease Index scores (OSDI) and Subjective Symptom Questionnaires (SSQs) were recorded at the same time point.
RESULTS: Thirty-eight eyes of 38 patients were enrolled. The noninvasive tear film break-up time (first break-up time and average break-up time) decreased in a peak at the 1wk visit, and then increased to basic levels at 1mo. The tear meniscus height (TMH) increased transiently at 1d, and declined in the following 3mo visits. The SIT had a transient increase at 1d (P=0.357) and a decrease at 1wk and 1mo (both P<0.05) but returned to the preoperative levels at 3mo after surgery (P=0.062). CFS scores were significantly improved compared with those before surgery, and had a statistical difference (P<0.05). OSDI scores and SSQs after surgery were obviously higher, and had a statistical difference (P<0.001) but didn't return to the basic level by 3mo.
CONCLUSION: Dry eye signs and symptoms can occur immediately following FLACS and have a peak severity on day 7 postoperatively. Most signs of dry eye can return to preoperative basic levels within 3mo postoperatively. However, all cases can not recover from CFS and dry eye symptoms at 3mo postoperatively.

Entities:  

Keywords:  dry eye; femtosecond laser-assisted cataract surgery; ocular surface; tear film

Year:  2019        PMID: 31341802      PMCID: PMC6629810          DOI: 10.18240/ijo.2019.07.11

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  7 in total

Review 1.  Prevalence and Characteristics of Dry Eye Disease After Cataract Surgery: A Systematic Review and Meta-Analysis.

Authors:  Maria Miura; Takenori Inomata; Masahiro Nakamura; Jaemyoung Sung; Ken Nagino; Akie Midorikawa-Inomata; Jun Zhu; Keiichi Fujimoto; Yuichi Okumura; Kenta Fujio; Kunihiko Hirosawa; Yasutsugu Akasaki; Mizu Kuwahara; Atsuko Eguchi; Hurramhon Shokirova; Akira Murakami
Journal:  Ophthalmol Ther       Date:  2022-05-09

2.  Alpha-Glycerylphosphorylcholine and D-Panthenol Eye Drops in Patients Undergoing Cataract Surgery.

Authors:  Gianluca Martone; Alessandra Balestrazzi; Giorgio Ciprandi; Angelo Balestrazzi
Journal:  J Ophthalmol       Date:  2022-06-07       Impact factor: 1.974

3.  Differential time-course tear film quantitative changes following limbal relaxing incisions.

Authors:  Mohamed Attia Ali Ahmed; Ahmed Shawkat Abdelhalim
Journal:  BMC Ophthalmol       Date:  2020-05-03       Impact factor: 2.209

Review 4.  Iatrogenic Dry Eye Disease: Dealing with the Conundrum of Post-Cataract Discomfort. A P.I.C.A.S.S.O. Board Narrative Review.

Authors:  Pasquale Aragona; Maurizio Rolando; Rita Mencucci; Roberto Vignapiano; Pierangela Rubino; Eleonora Favuzza; Emilia Cantera
Journal:  Ophthalmol Ther       Date:  2021-02-08

5.  Prevention of Surgery-Induced Dry Eye by Diquafosol Eyedrops after Femtosecond Laser-Assisted Cataract Surgery.

Authors:  Kenichiro Yamazaki; Junko Yoneyama; Ryuta Kimoto; Yuko Shibata; Tatsuya Mimura
Journal:  J Clin Med       Date:  2022-09-28       Impact factor: 4.964

6.  Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery: a protocol for a single-centre, randomised controlled trial.

Authors:  Maria Miura; Takenori Inomata; Shuko Nojiri; Jaemyoung Sung; Masashi Nagao; Jun Shimazaki; Akie Midorikawa-Inomata; Yuichi Okumura; Kenta Fujio; Yasutsugu Akasaki; Mizu Kuwahara; Tianxiang Huang; Masahiro Nakamura; Masao Iwagami; Kunihiko Hirosawa; Keiichi Fujimoto; Akira Murakami
Journal:  BMJ Open       Date:  2022-01-31       Impact factor: 2.692

Review 7.  Cataract surgery and dry eye disease: A review.

Authors:  Khayam Naderi; Jack Gormley; David O'Brart
Journal:  Eur J Ophthalmol       Date:  2020-06-09       Impact factor: 2.597

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.